Exact Sciences Stock (NASDAQ: EXAS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 492.000 / 1.936M |
Day Range | - - - |
52 Wk Range | 56.050 - 100.770 |
Market Cap | $12.141B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 65 |
Short Interest | 4.04% |
Days to Cover | 3.56 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Exact Sciences (NASDAQ: EXAS) through any online brokerage.
Other companies in Exact Sciences’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX), Cerevel Therapeutics Hldg (NASDAQ:CERE) and Roivant Sciences (NASDAQ:ROIV).
The latest price target for Exact Sciences (NASDAQ: EXAS) was reported by Canaccord Genuity on Thursday, February 22, 2024. The analyst firm set a price target for 90.00 expecting EXAS to rise to within 12 months (a possible 34.57% upside). 28 analyst firms have reported ratings in the last year.
The stock price for Exact Sciences (NASDAQ: EXAS) is $66.88 last updated Today at March 28, 2024 at 8:12 AM EDT.
There are no upcoming dividends for Exact Sciences.
Exact Sciences’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Exact Sciences.
Exact Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.